Sign in

CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company

Verastem, Inc.

Sign in to watch
Ticker
VSTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
273269467
Phone
(781) 292-4200
Business address
117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. S-3 Offering Registration Statement
  4. 10-Q Report Quarterly Report
  5. 8-K Event Regulation FD disclosure · Other events
  6. 4 Open-market sale President and CEO sold 820 shares at $7.30 ($5,986)
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. DEF 14A Proxy Proxy Statement
  12. 4 Grant or award Chief Operating Officer acquired 50,000 shares (grant or award)
  13. EFFECT Other Notice of Effectiveness
  14. 424B3 Offering Prospectus
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. UPLOAD Other SEC-generated Letter
  17. 4 Open-market sale Chief Financial Officer sold 91 shares at an average $6.93 ($631)
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. S-3 Offering Registration Statement
  20. 8-K Event Regulation FD disclosure

Page 9 of 53 · 1,058 filings